Why You Can’t Sleep Anymore: The Hormonal Explanation

You used to sleep well. Seven or eight hours, uninterrupted, waking rested. At some point in your late 30s or 40s, that changed. The onset was gradual enough that you cannot pinpoint when it started. You just know that sleep, which once required no effort, now requires strategy.

Perhaps you fall asleep easily but wake at 2 or 3 AM, alert and unable to return to sleep for an hour or more. Perhaps you sleep through the night but wake feeling as though you never slept at all. Perhaps your sleep is light, easily disturbed, and you spend more time in the shallow stages than in the restorative deep phases.

You have optimized your sleep hygiene. The room is dark and cool. Screens are off. Caffeine is limited to the morning. The improvements are marginal. The sleep still does not feel right.

The missing variable may be hormonal.

Progesterone and Sleep

Progesterone is metabolized in the brain into allopregnanolone, a potent modulator of GABA-A receptors. GABA is the brain’s primary inhibitory neurotransmitter, responsible for calming neural activity, facilitating the transition from wakefulness to sleep, and maintaining the depth and stability of sleep throughout the night.

Allopregnanolone enhances GABA receptor activity in a manner pharmacologically similar to benzodiazepines, though at a different binding site. When progesterone levels are adequate, this GABAergic support is continuous. When progesterone declines, as it does progressively through perimenopause, the calming signal weakens.

The clinical presentation is characteristic: the woman who wakes at 2 or 3 AM, or who reports a generalized difficulty achieving deep sleep. The timing is consistent with mid-luteal progesterone decline or, in early perimenopause, the anovulatory cycles that produce little to no progesterone at all.

Oral micronized progesterone taken at bedtime restores allopregnanolone production and, in many women, resolves the sleep disruption within days to weeks. This is one of the most consistent and rapidly observed benefits of progesterone replacement.

Estrogen and Sleep

Estrogen modulates thermoregulation, serotonin metabolism, and the hypothalamic centres that govern the sleep-wake cycle.

In perimenopause and menopause, declining and fluctuating estrogen destabilizes the hypothalamic thermostat. Hot flashes and night sweats are the most visible consequences, disrupting sleep through abrupt temperature spikes that trigger arousal. Even women who do not experience classic hot flashes may have subclinical thermoregulatory instability that fragments sleep without producing the subjective sensation of overheating.

Estrogen also supports serotonin synthesis, and serotonin is a precursor to melatonin. Declining estrogen can reduce melatonin production, impairing the circadian signal that initiates and maintains sleep.

Transdermal estradiol replacement stabilizes thermoregulation, reduces night sweats, and supports the serotonin-melatonin pathway. For women whose sleep disruption is driven by vasomotor symptoms or estrogen-mediated circadian instability, estradiol is the primary intervention.

Testosterone and Sleep

Testosterone’s relationship with sleep is bidirectional in both men and women.

Low testosterone is associated with increased prevalence of sleep-disordered breathing, including obstructive sleep apnea (OSA). OSA fragments sleep through repeated airway obstruction and arousal, reducing time in deep and REM sleep stages. Men with undiagnosed low testosterone and concurrent OSA are caught in a cycle where poor sleep further suppresses testosterone production.

Testosterone also influences sleep architecture independent of apnea. Men with low testosterone report reduced sleep quality, increased nocturnal wakefulness, and less restorative sleep. The mechanism involves testosterone’s effects on central neurotransmitter systems and on the inflammatory milieu that influences sleep regulation.

In women, testosterone contributes to overall neurological stability and energy regulation. Low testosterone may contribute to the non-specific sleep impairment that many perimenopausal women experience alongside the more specific effects of progesterone and estrogen decline.

Thyroid and Sleep

Both hypothyroidism and hyperthyroidism disrupt sleep, through different mechanisms.

Hypothyroidism, even subclinical, is associated with excessive daytime sleepiness, prolonged sleep latency, and reduced sleep quality. The metabolic slowing produced by inadequate thyroid hormone impairs the restorative function of sleep even when sleep duration is adequate.

Hyperthyroidism or thyroid hormone fluctuations (as can occur in early Hashimoto’s thyroiditis) produce hyperarousal, anxiety, and difficulty falling or staying asleep. The sympathetic nervous system activation that accompanies excess thyroid hormone creates a state incompatible with restful sleep.

A complete thyroid panel (TSH, free T3, free T4, and antibodies) is an essential component of any sleep-oriented hormonal assessment.

Cortisol and the 3 AM Wake-Up

Cortisol follows a diurnal rhythm: it peaks in the early morning (facilitating waking) and falls through the evening and night (permitting sleep). In a well-regulated system, cortisol is at its nadir between midnight and 3 AM.

Chronic stress, blood sugar instability, and adrenal dysfunction can flatten or invert this rhythm. Cortisol that rises too early in the night, or that fails to reach its nadir, produces arousal during the hours when sleep should be deepest.

The classic presentation is waking at 2 to 4 AM with a feeling of alertness or anxiety, often accompanied by a racing mind. The cortisol surge has prematurely activated the waking system. Returning to sleep is difficult because the biochemical signal for wakefulness is active.

This pattern overlaps with the progesterone-deficiency wakefulness described above. In many patients, both mechanisms contribute. A thorough assessment distinguishes between them and addresses both.

Blood Sugar and Sleep

Reactive hypoglycemia, a rapid drop in blood sugar following an insulin spike, triggers cortisol and adrenaline release as the body mobilizes glucose stores. This counter-regulatory response produces arousal, sometimes with sweating, heart pounding, and anxiety.

In insulin-resistant individuals, blood sugar may be unstable enough to trigger nocturnal hypoglycemic episodes that disrupt sleep without producing obvious symptoms. The patient wakes, feels wired, and has no idea that a glucose crash preceded the arousal.

This is where standard lab assessments fail. A fasting glucose may look normal. An HbA1c may be in range. Yet a continuous glucose monitor reveals the truth: large postprandial excursions, rapid drops, and nocturnal instability that no static blood test captures. Continuous glucose monitoring over 14 days, when correlated with meal timing and sleep patterns, identifies which foods and meal compositions provoke the glucose swings that fragment sleep. This level of metabolic visibility transforms sleep-oriented treatment from guesswork into precision intervention.

A Hormonal Sleep Assessment

A thorough evaluation for hormonal sleep disruption includes:

Progesterone (timed to cycle in premenopausal women), estradiol, total and free testosterone, SHBG, a complete thyroid panel, morning cortisol, fasting insulin, and fasting glucose. This baseline Pulsus assessment reveals what is, not what should be.

Wearable data (HRV, resting heart rate, sleep staging) provides longitudinal information about sleep architecture that a single night’s assessment cannot capture. Persistently low HRV during sleep despite adequate sleep duration often signals that the nervous system is not recovering—usually due to elevated cortisol, unstable blood sugar, or hormonal dysregulation that night-time blood work alone would miss. An overnight HRV trend is a window into the autonomic state during the hours when parasympathetic recovery should dominate.

Symptom mapping, including timing of wakefulness, associated symptoms (sweats, anxiety, palpitations), and correlation with the menstrual cycle, narrows the differential before any blood is drawn.

Treatment is targeted to the findings. Progesterone for GABA-mediated sleep disruption. Estradiol for thermoregulatory instability. Thyroid optimization for metabolic sleep impairment. Dietary and lifestyle modifications for cortisol and blood sugar mediated wakefulness. Often, multiple factors contribute, and the protocol addresses them in combination.

Sleep that was lost to hormonal decline can be restored. The assessment identifies the cause. The treatment addresses it specifically.

Continue Reading

If you found this useful, these related articles may deepen your understanding:

• Progesterone: The Most Underrated Hormone in Women’s Health
• Brain Fog in Your 40s
• HRV, Wearables, and Hormones

---

Dr. Handsun Xiao is a McGill trained physician (MD, CCFP) practicing functional medicine and bioidentical hormone therapy in Toronto, with virtual consultations available to patients across Ontario. He holds advanced BHRT certification through WorldLink Medical and IFM AFMCP training. Manus Solis offers physician led BHRT consultations with custom compounding through a dedicated Ontario pharmacy partner. To learn more or book a virtual consultation, visit manussolis.ca.